April L. Risinger
- Cell Biology top 5%
- Microtubule and mitosis dynamics 27
- Toxicology top 5%
- Organic Chemistry top 5%
- Synthesis and biological activity 5
- Oncology top 5%
- Cancer Treatment and Pharmacology 21
- Biotechnology top 5%
- Marine Sponges and Natural Products 7
-
- Phytochemical Studies and Bioactivities 17
- 14-3-3 protein interactions 17
- Cancer therapeutics and mechanisms 7
-
- Microbial Natural Products and Biosynthesis 15
- Co-authors
- Susan L. MooberryFrancis J. GilesNicholas F. Dybdal‐HargreavesLin DuJiangnan PengChris A. KaiserRobert H. CichewiczJing Li
- Partner nations
- United StatesEgyptSpain
In The Last Decade
April L. Risinger
72 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 98
- Cell Biology 413
- Toxicology 63
- Organic Chemistry 515
- Oncology 491
- Biotechnology 145
Countries citing papers authored by April L. Risinger
This map shows the geographic impact of April L. Risinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April L. Risinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April L. Risinger more than expected).
Fields of papers citing papers by April L. Risinger
This network shows the impact of papers produced by April L. Risinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April L. Risinger. The network helps show where April L. Risinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside April L. Risinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 10 | |
| 10 | 2019 | 23 | |
| 11 | 2018 | 5 | |
| 12 | 2017 | 42 | |
| 13 | 2015 | 7 | |
| 14 | 2014 | 28 | |
| 15 | 2011 | 25 | |
| 16 | 2010 | 31 | |
| 17 | 2008 | 111 | |
| 18 | 2008 | 44 | |
| 19 | 2006 | 47 | |
| 20 | 2004 | 29 |
About April L. Risinger
April L. Risinger is a scholar working on Cell Biology, Oncology and Pharmacology, having authored 78 papers that have together received 1.8k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (27 papers), Cancer Treatment and Pharmacology (21 papers), Phytochemical Studies and Bioactivities (17 papers), 14-3-3 protein interactions (17 papers), Microbial Natural Products and Biosynthesis (15 papers), Cancer therapeutics and mechanisms (7 papers), Marine Sponges and Natural Products (7 papers) and Synthesis and biological activity (5 papers). The work is most often cited by research in Cell Biology (413 citations), Toxicology (63 citations) and Organic Chemistry (515 citations). April L. Risinger has collaborated with scholars based in United States, Egypt and Spain. Frequent co-authors include Susan L. Mooberry, Francis J. Giles, Nicholas F. Dybdal‐Hargreaves, Lin Du, Jiangnan Peng, Chris A. Kaiser, Robert H. Cichewicz, Jing Li, Evelyn M. Jackson and Gregory L. Helms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.